These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27567559)

  • 1. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.
    Anitua E; Muruzabal F; de la Fuente M; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2016 Oct; 151():115-21. PubMed ID: 27567559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.
    Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F
    Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness.
    Etxebarria J; Sanz-Lázaro S; Hernáez-Moya R; Freire V; Durán JA; Morales MC; Andollo N
    Acta Ophthalmol; 2017 Dec; 95(8):e693-e705. PubMed ID: 28266180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.
    Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Fernandez-Vega Cueto L; Anitua E; Begoña L; Muruzabal F; Orive G
    Int Ophthalmol; 2018 Jun; 38(3):1193-1204. PubMed ID: 28620707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-A in Serum and Plasma Rich in Growth Factors (PRGF) Eye Drops.
    Sanak F; Baenninger P; Iselin K; Kaufmann C; Bachmann L; Buhl D; Thiel M
    Klin Monbl Augenheilkd; 2022 Apr; 239(4):378-381. PubMed ID: 35472775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum.
    Anitua E; Muruzabal F; Pino A; Prado R; Azkargorta M; Elortza F; Merayo-Lloves J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation.
    Anitua E; Sanchez M; Merayo-Lloves J; De la Fuente M; Muruzabal F; Orive G
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6066-73. PubMed ID: 21613374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage.
    Anitua E; de la Fuente M; Riestra A; Merayo-Lloves J; Muruzábal F; Orive G
    Cornea; 2015 Sep; 34(9):1144-8. PubMed ID: 26165790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of plasma rich in growth factors for the treatment of dry eye.
    López-Plandolit S; Morales MC; Freire V; Grau AE; Durán JA
    Cornea; 2011 Dec; 30(12):1312-7. PubMed ID: 22012030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery.
    Sanchez-Avila RM; Merayo-Lloves J; Fernandez ML; Rodriguez-Gutierrez LA; Jurado N; Muruzabal F; Orive G; Anitua E
    Ophthalmic Res; 2018; 60(2):80-86. PubMed ID: 29886478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease.
    Lozano-Sanroma J; Barros A; Alcalde I; Sánchez-Ávila RM; Queiruga-Piñeiro J; Fernández-Vega Cueto L; Merayo-Lloves J
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241160
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders.
    Merayo-Lloves J; Sanchez RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
    Ophthalmic Res; 2015; 55(2):53-61. PubMed ID: 26569104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops.
    Anitua E; de la Fuente M; Muruzábal F; Merayo-Lloves J
    Cornea; 2021 Jan; 40(1):107-112. PubMed ID: 32947409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF).
    Anitua E; de la Fuente M; Muruzabal F; Sánchez-Ávila RM; Merayo-Lloves J; Azkargorta M; Elortza F; Orive G
    PLoS One; 2018; 13(10):e0205073. PubMed ID: 30312303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome.
    Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Anitua E; Muruzabal F; Orive G; Fernández-Vega L
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):391-399. PubMed ID: 28375790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America.
    Soifer M; Tovar A; Wang M; Mousa HM; Yennam S; Sabater AL; Pflugfelder SC; Perez VL
    Ocul Surf; 2022 Jul; 25():40-48. PubMed ID: 35489588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology.
    Anitua E; de la Fuente M; Alcalde I; Sanchez C; Merayo-Lloves J; Muruzabal F
    Transl Vis Sci Technol; 2020 Jun; 9(7):35. PubMed ID: 32832240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye.
    Merayo-Lloves J; Sanchez-Avila RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
    Ophthalmic Res; 2016 Jul; 56(2):68-73. PubMed ID: 27229893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.